GB9414208D0 - Compounds - Google Patents

Compounds

Info

Publication number
GB9414208D0
GB9414208D0 GB9414208A GB9414208A GB9414208D0 GB 9414208 D0 GB9414208 D0 GB 9414208D0 GB 9414208 A GB9414208 A GB 9414208A GB 9414208 A GB9414208 A GB 9414208A GB 9414208 D0 GB9414208 D0 GB 9414208D0
Authority
GB
United Kingdom
Prior art keywords
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB9414208A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to GB9414208A priority Critical patent/GB9414208D0/en
Publication of GB9414208D0 publication Critical patent/GB9414208D0/en
Application status is Pending legal-status Critical

Links

GB9414208A 1994-07-14 1994-07-14 Compounds Pending GB9414208D0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB9414208A GB9414208D0 (en) 1994-07-14 1994-07-14 Compounds

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9414208A GB9414208D0 (en) 1994-07-14 1994-07-14 Compounds
PCT/EP1995/002705 WO1996002543A1 (en) 1994-07-14 1995-07-12 2,3-dihydroxy cyclopentane derivatives of purines
AU29829/95A AU2982995A (en) 1994-07-14 1995-07-12 2,3-dihydroxy cyclopentane derivatives of purines

Publications (1)

Publication Number Publication Date
GB9414208D0 true GB9414208D0 (en) 1994-08-31

Family

ID=10758317

Family Applications (1)

Application Number Title Priority Date Filing Date
GB9414208A Pending GB9414208D0 (en) 1994-07-14 1994-07-14 Compounds

Country Status (3)

Country Link
AU (1) AU2982995A (en)
GB (1) GB9414208D0 (en)
WO (1) WO1996002543A1 (en)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW528755B (en) 1996-12-24 2003-04-21 Glaxo Group Ltd 2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives
YU44900A (en) 1998-01-31 2003-01-31 Glaxo Group Limited 2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives
NZ506234A (en) * 1998-02-26 2003-05-30 Aventis Pharma Inc 6,9-Disubstituted 2-[trans-(4-aminocyclohexyl)amino]purines, pharmaceuticals thereof and their use for inhibiting cdk-2
US6479487B1 (en) 1998-02-26 2002-11-12 Aventis Pharmaceuticals Inc. 6, 9-disubstituted 2-[trans-(4-aminocyclohexyl)amino] purines
US6413974B1 (en) 1998-02-26 2002-07-02 Aventis Pharmaceuticals Inc. 6,9,-disubstituted 2-[trans-(4-aminocyclohexyl) amino] purines
AT246701T (en) 1998-06-23 2003-08-15 Glaxo Group Ltd 2- (purin-9-yl) -tetrahydrofuran-3,4-diol derivatives
JP2002193967A (en) * 2000-07-10 2002-07-10 Sumika Fine Chemicals Co Ltd Production method of 2,6-dichloropurine
US6861524B2 (en) 2000-10-31 2005-03-01 Aventis Pharmaceuticals Inc. Acyl and sulfonyl derivatives of 6,9-disubstituted 2-(trans-1,4-diaminocyclohexyl)-purines and their use as antiproliferative agents
TW200519106A (en) 2003-05-02 2005-06-16 Novartis Ag Organic compounds
GB0401334D0 (en) 2004-01-21 2004-02-25 Novartis Ag Organic compounds
PE02722006A1 (en) 2004-05-24 2006-05-22 Glaxo Group Ltd (2R, 3R, 4S, 5R, 2'R, 3'R, 4's, 5's) -2,2 '- {trans-1,4-ciclohexanodiilbis- [imino (2 - {[2- (1-methyl- 1H-imidazol-4-yl) ethyl] amino} -9 H -purine-6,9-diyl)]} bis [5- (2-ethyl-2H-tetrazol-5-yl) tetrahydro-3,4-furandiol] a2a agonist
GB0424284D0 (en) 2004-11-02 2004-12-01 Novartis Ag Organic compounds
GB0426164D0 (en) 2004-11-29 2004-12-29 Novartis Ag Organic compounds
GB0510390D0 (en) 2005-05-20 2005-06-29 Novartis Ag Organic compounds
GB0514809D0 (en) 2005-07-19 2005-08-24 Glaxo Group Ltd Compounds
KR101461263B1 (en) 2005-10-21 2014-11-17 노파르티스 아게 Human antibodies against IL-13 and therapeutic uses
GB0601951D0 (en) 2006-01-31 2006-03-15 Novartis Ag Organic compounds
CA2664378A1 (en) 2006-09-29 2008-04-03 Novartis Ag Pyrazolopyrimidines as pi3k lipid kinase inhibitors
KR20090075714A (en) 2006-10-30 2009-07-08 노파르티스 아게 Heterocyclic compounds as antiinflammatory agents
EA201001129A1 (en) 2008-01-11 2011-02-28 Новартис Аг Pyrimidines as kinase inhibitors
PT2391366E (en) 2009-01-29 2013-02-05 Novartis Ag Substituted benzimidazoles for the treatment of astrocytomas
US8389526B2 (en) 2009-08-07 2013-03-05 Novartis Ag 3-heteroarylmethyl-imidazo[1,2-b]pyridazin-6-yl derivatives
CA2770873A1 (en) 2009-08-12 2011-02-17 Novartis Ag Heterocyclic hydrazone compounds and their uses to treat cancer and inflammation
LT2467141T (en) 2009-08-17 2019-02-11 Intellikine, Llc Heterocyclic compounds and uses thereof
EP2467383A1 (en) 2009-08-20 2012-06-27 Novartis AG Heterocyclic oxime compounds
WO2012034095A1 (en) 2010-09-09 2012-03-15 Irm Llc Compounds and compositions as trk inhibitors
UY33597A (en) 2010-09-09 2012-04-30 Irm Llc Compounds and compositions as inhibitors of trk
JP2014505088A (en) 2011-02-10 2014-02-27 ノバルティス アーゲー [1,2,4] Triazolo [4,3-b] pyridazine compounds as C-MET tyrosine kinase inhibitors
WO2012116237A2 (en) 2011-02-23 2012-08-30 Intellikine, Llc Heterocyclic compounds and uses thereof
KR20140014184A (en) 2011-02-25 2014-02-05 아이알엠 엘엘씨 Compounds and compositions as trk inhibitors
UY34329A (en) 2011-09-15 2013-04-30 Novartis Ag Triazolopyridine compounds
CA2856803A1 (en) 2011-11-23 2013-05-30 Intellikine, Llc Enhanced treatment regimens using mtor inhibitors
EP2834246A4 (en) 2012-04-03 2015-10-28 Novartis Ag Combination products with tyrosine kinase inhibitors and their use
WO2014151147A1 (en) 2013-03-15 2014-09-25 Intellikine, Llc Combination of kinase inhibitors and uses thereof
WO2015084804A1 (en) 2013-12-03 2015-06-11 Novartis Ag Combination of mdm2 inhibitor and braf inhibitor and their use
US10195208B2 (en) 2014-07-31 2019-02-05 Novartis Ag Combination therapy

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0267878A1 (en) * 1986-11-14 1988-05-18 Ciba-Geigy Ag N9-cyclopentyl-substituted adenine derivatives
GB8826205D0 (en) * 1988-11-09 1988-12-14 Wellcome Found Heterocyclic compounds
GB8926417D0 (en) * 1989-11-22 1990-01-10 Wellcome Found Heterocyclic compounds
CA2092305C (en) * 1990-09-25 2003-02-11 Alfred P. Spada Compounds having antihypertensive and anti-ischemic properties

Also Published As

Publication number Publication date
AU2982995A (en) 1996-02-16
WO1996002543A1 (en) 1996-02-01

Similar Documents

Publication Publication Date Title
DE69530493D1 (en) Ablationsgerät
DE69528655D1 (en) Asymmetrische femorale prothese
DE69531947D1 (en) Ausbreitbare ringprothese
GB2294043B (en) Bisresorcinyltriazines
DE69524254D1 (en) Nadelmagazin
DE69502378D1 (en) Metalloproteinaseinhibitoren
DE69529412D1 (en) Hydromorphone-therapie
DE69512891D1 (en) Metalloproteinaseinhibitoren
DE69532245D1 (en) Imidazolderivat
DE69512030D1 (en) Cerebral-dilator
DE59508177D1 (en) Modulare hüftgelenkprothese
DE69528457D1 (en) Modulares blockwand-haltesystem
GB2293823B (en) 2-Hydroxyphenyltriazines
DE69522947D1 (en) Phenylxanthin-derivate
DE69523560D1 (en) Fluorinzelle
DE69534962D1 (en) Htk-ligand
DE69531859D1 (en) Bioumbaubare collagentransplantat prothese
DE69534778D1 (en) Cathepsin-02-protease
DE69533314D1 (en) Polyester-isolation
DE69526822D1 (en) Xanthin-derivate
DE69506554D1 (en) Schrumpfbares originalitätsband
GR3031464T3 (en) Polyolpolyhydroxystearates
EP0696731A3 (en) Cytoanalyzer
HRP950428A2 (en) Benzoxazolyl- and benzo-thiazolyl-oxazolidinones
GB9408577D0 (en) New compound